Therapeutic potential of a polyherbal extract against COVID-19 and associated inflammation and mucormycosis: In vitro characterization and in vivo validation in a human coronavirus 229E–infected mouse model
Fields of Study & Subjects
Antifungal resistance and susceptibility
SARS-CoV-2 and COVID-19 Research
COVID-19 Clinical Research Studies
Publication details
- Journal / source
- Annales Pharmaceutiques Françaises
- Publisher
- Elsevier BV
- Volume
- 84
- Issue
- 4
- Pages
- 662–685
- Publication date
- 22 January 2026
- Language
- EN